NCCN Guidelines Insights
Medscape InDiscussion: Advanced and Metastatic Breast Cancer
... insights and practical ideas for optimizing patient care. Relevant ... NCCN Guidelines® Insights: Breast Cancer, Version 4.2021 https://pubmed.ncbi.nlm ...
NCCN Guidelines® Insights - Systemic Mastocytosis, Version 3.2024
The NCCN Guidelines for Systemic Mastocytosis provide evidence- and consensus-based recommendations for the diagnosis and comprehensive care ...
Successful Treatment With Lorlatinib Monotherapy for Secondary ...
... (NCCN) guidelines, therapeutic challenges arise in cases of disease progression. ... insights: Non-small cell lung cancer, version 2.2023. J ...
Monograph/Journal Supplement - NCCN Continuing Education |
These NCCN Guidelines Insights highlight recent guideline updates pertaining to the management of emerging toxicities related to cancer immunotherapy. NCCN ...
NCCN Guidelines® Insights - Cervical Cancer, Version 1.2024
These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.
National Comprehensive Cancer Network - Home
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 33 leading cancer centers devoted to patient care, research, and education, ...
NCCN Guidelines® Insights - B-Cell Lymphomas, Version 6.2023
These NCCN Guideline Insights highlight the significant updates to the NCCN Guidelines for B-Cell Lymphomas for the treatment of FL, DLBCL, and MCL.
NCCN Guidelines® Insights - Myelodysplastic Syndromes, Version ...
These NCCN Guidelines Insights focus on some of the updates for the 2022 version of the NCCN Guidelines, which include treatment recommendations both for ...
Rectal Cancer - Guidelines Detail - NCCN
Educational Events and Programs · NCCN Guidelines® Insights - Rectal Cancer, Version 3.2024 · Management of MSI-H/dMMR Upper and Lower Gastrointestinal Cancers.
NCCN Guidelines® Insights - Distress Management, Version 2.2023
All patients experience some level of distress associated with a cancer diagnosis and the effects of the disease and its treatment ...
NCCN Guidelines® Insights - Melanoma: Cutaneous, Version 2.2024
These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by ...
NCCN Guidelines® Insights - Mesothelioma: Pleural, Version 1.2024
These NCCN Guidelines Insights highlight significant updates to the NCCN Guidelines for Mesothelioma: Pleural, including revised guidance on ...
NCCN Guidelines® Insights - Kidney Cancer, Version 2.2024
These NCCN Guidelines Insights focus on the systemic therapy options for patients with advanced renal cell carcinoma and summarize the new ...
NCCN Guidelines® Insights - Prostate Cancer, Version 3.2024
These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk ...
Trends Surveys and Data - NCCN
NCCN Trends™ Surveys and Data are independent of any NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) or other NCCN clinical recommendations.
Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal ... - NCCN
Educational Events and Programs · Archived Monthly Oncology Tumor Boards: Management of Advanced Ovarian Cancer · NCCN Guidelines® Insights - Ovarian Cancer/ ...
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment
These NCCN Guidelines Insights summarize important updates regarding: (1) a new section for transgender, nonbinary and gender diverse people who have a ...
NCCN Guidelines® Insights - Bladder Cancer, Version 3.2024
These NCCN Guidelines Insights detail recent updates to the NCCN Guidelines for Bladder Cancer, including changes in the fifth edition of ...
Bladder Cancer - Guidelines Detail - NCCN
Educational Events and Programs · NCCN Guidelines® Insights - Bladder Cancer, Version 3.2024 · Updates in the Treatment of Metastatic Urothelial Cancer · NCCN ...
Head and Neck Cancers - Guidelines Detail - NCCN
No portion of this Site or any NCCN Content may be copied, transferred, reproduced, modified, or otherwise used for any purpose without NCCN's express written ...